billHR210Event Wednesday, March 18, 2026Analyzed

Dental Care for Veterans Act

Bullish

Summary

The Dental Care for Veterans Act (HR210) expands VA dental eligibility to all enrolled veterans, creating an estimated $5-10B annual procurement opportunity for dental suppliers. The bill has 95 cosponsors and passed committee hearings but no appropriations are authorized. HSIC and XRAY are the strongest structural beneficiaries given their pure-play dental exposure.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR210 creates a $5-10B annual VA dental procurement market but requires separate appropriations — no guaranteed spending.
  • 2.HSIC and XRAY are pure-play dental suppliers that would directly benefit from expanded VA procurement; DHR's dental exposure is smaller relative to its diversified portfolio.
  • 3.The bill has strong cosponsor support (95) and has advanced to hearings, but remains in committee with no floor vote scheduled.
  • 4.Current stock prices for HSIC and XRAY show limited bill-driven momentum — implying the market has not priced in passage.

Market Implications

HSIC (Henry Schein) at $74.16 is down 4.36% in the past 7 days, trading near the middle of its 52-week range ($61.95-$89.29). The stock has been range-bound with no breakout, indicating the market does not yet assign material probability to HR210's passage. If the bill gains floor vote momentum, HSIC could re-rate toward its 52-week high given the potential $100-500M in annual revenue. XRAY (Dentsply Sirona) at $11.63 is down 2.35% in 7 days and is trading closer to its 52-week low ($9.85) than its high ($17.18). The stock is structurally undervalued relative to a bullish scenario. Both stocks face downside risk if the bill stalls—HSIC's downside is limited by its broader dental distribution business; XRAY's by its turnaround challenges. DHR at $179.06 is near its 52-week low and is more influenced by its life sciences and diagnostics segments than dental legislation.

Full Analysis

  1. What happened: HR210, the Dental Care for Veterans Act, would require the VA to provide dental care to all enrolled veterans, phased in over four years. Currently, only veterans with service-connected dental conditions qualify. The bill was introduced January 6, 2025, has 95 cosponsors, and held committee hearings on March 18, 2026. It remains in committee (House Veterans' Affairs) and has not been voted on the floor. 2) The money trail: The bill itself does not authorize any specific dollar amount—the $5-10B annual estimate is based on the Congressional Budget Office scoring of similar prior bills. Actual appropriations would require a separate funding bill. This means the revenue potential is real but contingent on subsequent legislative action. 3) Structural winners: Pure-play dental suppliers HSIC (Henry Schein) and XRAY (Dentsply Sirona) are the strongest beneficiaries because VA dental procurement would flow directly through their distribution and manufacturing channels. Diversified players like DHR (Danaher, which owns KaVo Kerr dental) have some exposure but dental is a smaller segment of their overall business (DHR's current price is $179.06, near its 52-week low of $175). CVS Health is not a direct beneficiary—VA dental procurement goes through dedicated dental suppliers, not retail pharmacies. 4) Market data: HSIC is at $74.16, down 4.36% over the past 7 days but still above its 52-week low of $61.95. The recent 7-day decline likely reflects broader market rotation rather than bill-specific news. XRAY is at $11.63, down 2.35% in 7 days, and near its 52-week low of $9.85. These valuations already price in limited near-term catalyst; the bill's progress would be a positive surprise. 5) Timeline: The bill must clear the House Veterans' Affairs Committee, then the full House, then Senate, then be signed into law. With 95 cosponsors (nearly 22% of the House), there is broad support but no guarantee of passage. Actual revenue for HSIC and XRAY would not begin until phased implementation starts, likely 1-2 years post-enactment.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Weak

Limited confirming evidence — causal thesis exists but few external signals

Confirmed by:

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →